通过补充小剂量脂质营养补充剂激励提高6至23月龄儿童麻疹疫苗接种覆盖率:尼日利亚北部约贝州NutriVax-Measles优势实用平行整群随机对照试验研究方案
该研究为在尼日利亚约贝州20个选区开展的两臂优势实用平行整群随机对照试验,将选区按1:1随机分配至标准国家免疫规划组或国家免疫规划联合小剂量脂质营养补充剂分发组。实施至多12个月后,在12-23月龄儿童中评估人群水平麻疹免疫覆盖率(主要结局),在6-12月龄儿童中评估个体水平覆盖率(关键次要结局)。
要点
- 将小剂量脂质营养补充剂分发整合至常规免疫服务,可能同时作为营养干预和增加疫苗接种的激励措施。
- 主要结局为12-23月龄儿童人群水平麻疹免疫覆盖率,通过终点横断面调查评估。
- 关键次要结局为6-12月龄儿童个体水平覆盖率,通过纵向调查评估。
核心结论
- 据作者所知,这是首个评估预防性营养补充剂是否也可作为激励措施以提高疫苗接种覆盖率的试验。
- 研究结果将为营养不良率高和免疫覆盖率低持续构成重大公共卫生挑战的地区提供指导政府和捐助者的证据。
研究设计与样本
- 在尼日利亚东北部约贝州Nguru和Karasuwa地方政府区的20个选区开展两臂优势实用平行整群随机对照试验,并设基线测量。
- 选区按1:1随机分配至标准国家免疫规划(NPI)组或NutriVax组(NPI联合小剂量脂质营养补充剂分发)。
- 实施至多12个月后评估麻疹免疫覆盖率:12-23月龄儿童人群水平覆盖率(主要结局,终点横断面调查)和6-12月龄儿童个体水平覆盖率(关键次要结局,纵向调查)。
- 每次横断面调查(基线和终点)纳入1560名参与者,纵向调查纳入600名参与者。
- 采用多阶段抽样设计,按概率与规模成比例及系统随机家庭选择;所有结局按意向性治疗分析;通过定性访谈评估可行性和可接受性;采用增量成本效率比估计两臂间成本效率差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Undernutrition and infectious diseases form a vicious cycle that poses a dual threat to vulnerable children in low- and middle-income countries. Integrating small-quantity lipid-based nutrient supplements (SQ-LNS) distribution into routine immunization services in children 6-23 months may act as both a nutritional intervention and as an incentive for increased vaccine uptake. METHODS: We will conduct a two-arm superiority pragmatic parallel cluster-randomized controlled trial with baseline measures in 20 wards of Nguru and Karasuwa Local Government Areas, Yobe State, Northeast Nigeria. Wards will be randomly allocated 1:1 to either the standard National Program on Immunization (NPI) arm or the NutriVax arm, which combines NPI with SQ-LNS distribution. After up to 12 months of implementation, measles immunization coverage will be assessed at two levels: population-level coverage in children aged 12-23 months (primary outcome, endline cross-sectional survey) and individual-level coverage in children aged 6-12 months (key secondary outcome, longitudinal survey). Each cross-sectional survey (baseline and endline) will include 1560 participants. The longitudinal survey will enroll 600 participants. Sampling will use a multi-stage design with probability proportional to size and systematic random household selection. All outcomes will be analyzed by intention-to-treat. Qualitative interviews will assess feasibility and acceptability. Cost-efficiency differences between arms will be estimated using an incremental cost-efficiency ratio. DISCUSSION: To our knowledge, this is the first trial to evaluate whether a preventive nutrition supplement can also serve as an incentive to increase vaccination coverage. Findings will provide evidence to guide governments and donors in settings where high rates of undernutrition and low immunization coverage persist as major public health challenges. TRIAL REGISTRATION: Protocol Number NCT06387511 (clinicaltrials.gov).
引用
- Cazes C, Goni BW, Muhammad NS, et al. Increasing measles vaccination coverage through supplementation with an SQ-LNS incentive in children aged 6 to 23 months: study protocol of NutriVax-Measles, a superiority pragmatic parallel cluster-randomized controlled trial in Yobe State, Northern Nigeria. Trials. 2025. PMID: 41257898. doi:10.1186/s13063-025-09243-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。